All In Biotech

Drug Trial Radar · NCT00000218

Pharmacotherapy and Intensive Treatment - 2

Pharmacotherapy and Intensive Treatment

Last checked: Nov 20, 2026Latest source record: Jan 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

353

Actual

Start

Not stated

Primary completion

Not stated

Study completion Jun 2005

Sponsor

Sponsor type
NIH
Collaborators
VA Office of Research and Development
First posted
Sep 21, 1999

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.

Conditions

  • Cocaine-Related Disorders
  • Substance-Related Disorders

Interventions

  • CarbamazepineDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Severity addiction
  2. Depression
  3. Depression, anxiety

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Kansas

    Kansas City, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.